New York Senate Bill S09053

New York 2025-2026 Regular Session

• Introduced: 1/28/26
• Refer: 1/28/26

Caption

Directs the commissioner of health to conduct a study on kratom use by humans and to submit a report on such study after one year.

Summary

This bill directs the New York State Commissioner of Health to conduct a comprehensive study on kratom use by humans. The study must examine kratom’s potential health risks, benefits, and effects, and it may include other relevant aspects of human use as determined by the commissioner. The commissioner must submit a report of findings and any recommendations to the Governor and legislative leaders within one year after the act takes effect. The bill does not itself regulate kratom, ban it, or create penalties; instead, it establishes a fact-finding process intended to inform future policy decisions. In practical terms, the bill would add a new research and reporting obligation for the Department of Health, but it would not directly amend existing controlled substance, public health, or consumer protection statutes. Its main impact would be to generate an official state assessment of kratom, which could later influence legislation, regulation, or public health guidance affecting consumers, healthcare providers, retailers, and policymakers. The general sentiment reflected by the bill’s text is cautious and informational rather than punitive. Because there are no committee transcripts or recorded votes provided, there is no evidence of formal debate or opposition in the available record. The bill’s structure suggests an interest in understanding kratom’s effects before taking any broader regulatory action. The main point of contention likely concerns kratom itself: whether it should be treated as a potentially beneficial herbal product, a public health risk, or something in between. Any future debate would likely center on the reliability of available scientific evidence, the balance between consumer access and safety concerns, and whether a study is sufficient or whether immediate regulation is warranted.

Impact

The bill would require the Department of Health to undertake a new study and issue a report, but it would not directly change the legal status of kratom or amend any existing statute. Its legal effect is limited to creating an administrative research mandate and a reporting deadline, with the possibility that the resulting findings could support future legislative or regulatory changes affecting kratom-related products and users.

Sentiment

No committee discussion or vote history is available, so there is no documented legislative sentiment beyond the bill’s text. The measure appears neutral and exploratory, reflecting a policy approach focused on gathering evidence about kratom rather than endorsing or restricting its use. The absence of recorded opposition or support in the provided materials means any broader sentiment can only be inferred as cautious and study-oriented.

Contention

The likely area of contention is kratom’s health profile and how the state should respond to it. Supporters of the bill would likely favor a state-sponsored review to clarify benefits and risks, while critics may argue that a study delays action on a substance they view as unsafe or, alternatively, that it could be used to justify unnecessary restrictions on a product some consumers use for pain relief or self-treatment. The central dispute is whether the state needs more evidence before acting and what policy conclusions, if any, should follow from the study.